文献速递抗栓抗凝管理特殊人群用药治疗药物监测与药物基因组学

老年患者对机构肝素方案抗凝敏感性评估:基于初始抗Xa因子水平

Evaluating anticoagulation sensitivity among elderly patients managed with an institution's heparin protocol using initial anti-factor Xa levels.
PubMed 文献 · Am J Health Syst Pharm · 2020-01-01

该回顾性队列研究纳入2016年2月11日至2017年8月1日因手术、急性冠脉综合征或深静脉血栓/肺栓塞住院并接受普通肝素治疗的成人患者,比较老年(≥70岁)与非老年(18-69岁)患者初始抗Xa因子水平。结果显示老年患者在ACS、DVT/PE和手术方案中初始抗Xa水平均显著高于非老年患者,仅ACS方案中老年患者高于目标范围的比例增加,提示需进一步研究老年患者肝素敏感性是否需单独剂量方案。

要点

  • 老年患者在ACS、DVT/PE和手术肝素方案中初始抗Xa水平均显著高于非老年患者。
  • 仅ACS方案中老年患者抗Xa水平高于目标范围的比例显著增加。
  • 研究提示需进一步探讨老年患者是否需单独肝素剂量方案。

核心结论

  • 老年患者在所有肝素方案中初始抗Xa水平均显著高于非老年成人患者。
  • 仅ACS方案中老年患者抗Xa水平高于目标范围的比例显著增加。
  • 研究提示需进一步研究老年患者肝素敏感性增加是否需单独剂量方案。

研究设计与样本

  • 回顾性队列研究,纳入2016年2月11日至2017年8月1日住院的成人患者。
  • 患者因手术、急性冠脉综合征或深静脉血栓/肺栓塞接受普通肝素治疗。
  • 共纳入325例患者,其中老年(≥70岁)150例,非老年(18-69岁)175例。
  • 比较方案启动后抗Xa水平与机构目标范围0.3至0.7 IU/mL。

主要发现

  • 老年患者ACS方案初始抗Xa水平高于非老年患者,P=0.02。
  • 老年患者DVT/PE方案初始抗Xa水平高于非老年患者,P<0.001。
  • 老年患者手术方案初始抗Xa水平高于非老年患者,P=0.01。
  • 仅ACS方案中老年患者抗Xa水平高于目标范围的比例增加,P=0.03。

关键数值与推荐

  • 机构肝素方案目标抗Xa水平范围为0.3至0.7 IU/mL。
  • 老年患者定义为70岁及以上,非老年成人为18至69岁。

临床怎么用

  • 临床药师应关注老年患者使用机构肝素方案时初始抗Xa水平可能偏高。
  • 对于ACS方案的老年患者,需警惕抗Xa水平高于目标范围的风险。
  • 现有数据支持进一步研究以确定老年患者是否需调整肝素剂量方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to assess an institution's heparin protocols in elderly and nonelderly adult populations to see if a response difference was observed. METHODS: This was a retrospective cohort study of hospitalized adults who were prescribed unfractionated heparin due to surgery, acute coronary syndrome (ACS), or deep vein thrombosis/pulmonary embolism (DVT/PE) from February 11, 2016, through August 1, 2017. Patients were divided into nonelderly adults 18 to 69 years of age and elderly patients 70 years of age or older. The anti-factor Xa (anti-Xa) level after protocol initiation was compared to the institution's goal range of 0.3 to 0.7 IU/mL. Outcomes of each protocol in the elderly population were compared to outcomes in their nonelderly counterparts to determine if there was a difference in heparin response. RESULTS: A total of 325 patients were included in the analysis, comprising 150 elderly and 175 nonelderly adults. Elderly patients had a higher initial anti-Xa levels than did their nonelderly adult counterparts in the ACS, DVT/PE, and surgery protocols, with P values of 0.02, <0.001, and 0.01, respectively. Only the ACS protocol demonstrated increased frequency of above-target-level anti-Xa levels in the elderly (P = 0.03). CONCLUSION: Elderly patients had significantly higher initial anti-Xa levels than did nonelderly adult patients across all protocols. This study identifies the need to further study elderly patients' increased heparin sensitivity to determine if a separate dosing protocol is needed.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Lemke A, Kohs J, Weber L, et al. Evaluating anticoagulation sensitivity among elderly patients managed with an institution's heparin protocol using initial anti-factor Xa levels. Am J Health Syst Pharm. 2020. PMID: 31985745. doi:10.1093/ajhp/zxz304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。